All Posts: cancer research
-
With a New ‘Map’ of Cells, Georgetown Cancer Researchers Chart a Course to More Effective Treatment
Faculty and students from Biomedical Graduate Education programs, the School of Medicine and Lombardi Comprehensive Cancer Center are developing a new technique that could revolutionize the way cancers are tracked and treated. Instead of invasive surgical biopsies or time-consuming scans, clinicians could use simple blood tests to determine where the cancer is and whether it is responding to treatment.
Category: Lombardi Stories
-
Months After Chemotherapy, MD/PhD Student Bikes 50 Miles for Cancer Research
A year and a half into medical school at Georgetown, Bryan Weselman was diagnosed with cancer. Now, he’s researching cancer to improve treatment for other patients.
Category: Lombardi Stories
-
Georgetown Lombardi’s Jeffrey Toretsky, MD, Honored with Hyundai Hope on Wheels Endowed Chair in Pediatric Oncology
Hyundai Hope On Wheels, one of the largest nonprofit funders of pediatric cancer research in the country, has awarded its first Hyundai Hope on Wheels Endowed Chair for Pediatric Oncology to Jeffrey Toretsky, MD, at Georgetown’s Lombardi Comprehensive Cancer Center.
Category: Lombardi Stories
-
Identifying ‘Stealth’ Sources of Saturated Fat, Added Sugar in the Diet
A newly compiled list of foods and drinks commonly consumed in the United States hints at why many adults unknowingly overdo it on saturated fat and added sugar in their daily diet, a new study suggests.
Category: Lombardi Stories
-
Countdown to BellRinger: 100 Days Until the Community Bike Ride to End Cancer
Thursday, July 19, 2024, marks 100 days until BellRinger, a bike ride and community movement to end cancer. With efforts to build teams of Riders and fundraising gearing up quickly, BellRinger will take place on October 26, 2024, bringing together Riders of all levels: avid cyclists, casual riders, and people who simply hate cancer – all united in their desire to support cancer research at Georgetown University’s Lombardi Comprehensive Cancer Center, DC’s only cancer center federally designated by the National Cancer Institute.
Category: News Release
-
The Aspirin Conundrum: Navigating Negative Results, Age, Aging Dynamics and Equity
A new study examining the role of aspirin in breast cancer treatment reveals critical issues related to health equity and aging that have broad implications for cancer and other disease intervention trials, say researchers from Georgetown University’s Lombardi Comprehensive Cancer Center. They outline their concerns in an editorial accompanying the study’s findings published April 29 in the JAMA.
Category: News Release
-
Could a Georgetown Lab Finding Lead to New Treatment in Pancreatic Cancer?
For the first time, new research by Georgetown scientists shows potential to make immunotherapy effective in pancreatic cancer by combining it with a drug that makes cancer cells more responsive to immunotherapy. The research is now in a phase 2 clinical trial being tested in human patients.
Category: Lombardi Stories
-
Understanding Immunotherapy Resistance Leads to New Therapeutic Strategies — and Hope
Samir Khleif, MD, an immunologist and professor of oncology at Georgetown Lombardi, is working to understand why some cancers become resistant to immunotherapy, and how that resistance can be overcome.
Category: Lombardi Stories
-
Ruesch Center Symposium Focuses on Early-Onset GI Cancer
With an emphasis on early-onset gastrointestinal cancer, the 14th Annual Ruesch Center Symposium brought together nearly 300 health care providers, researchers, advocates, patients and caregivers November 16-18 to honor those dedicated to curing GI cancers, discuss the experiences of patients and caregivers, and share the latest research in the field.
Category: Lombardi Stories
-
Computer Models Fill Critical Knowledge Gaps To Help Reduce Cancer Disparities
Reducing health disparities in incidence and mortality for major types of cancers can be aided by sophisticated computer modeling efforts, according to a new, wide-ranging perspective by researchers at Georgetown University’s Lombardi Comprehensive Cancer Center and colleagues. A collection of new studies in the November 8, 2023, special issue of JNCI devoted to cancer disparities modeling outlines a path forward.
Category: News Release